CAI
Caris Life Sciences, Inc.
31.70$
+0.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.5% | 61.4% | 59.0% | 43.9% | 44.5% | 41.6% | 61.0% | 94.2% | -110.5% | -90.2% | -59.5% | 10.2% | |
| 32.2% | 34.6% | 45.8% | 36.2% | 32.5% | 28.6% | 27.4% | 37.6% | 18.7% | 16.0% | 11.9% | 2.8% | |
| 0.7% | 0.8% | 0.8% | 0.6% | 0.6% | 0.7% | 0.7% | 0.6% | 8.9% | 5.0% | 4.5% | 8.6% | |
| -6.7% | -34.5% | 12.3% | 15.3% | -26.0% | -19.9% | 100.2% | -107.9% | -8.6% | -2.3% | -7.1% | -4.1% | |
| 147.0% | 135.0% | 156.0% | 85.4% | 144.1% | 188.1% | 76.6% | 74.6% | 16.3% | 7.3% | 2.0% | 2.0% | |
| -125.6% | -99.0% | -122.3% | -61.7% | -118.2% | -153.5% | -65.3% | -11.6% | -109.5% | 70.2% | 12.8% | -2.0% | |
| – | – | – | – | – | 0.8% | 2.1% | 6.0% | – | – | – | – | |
| – | -13.8% | -5.2% | -3.1% | – | -9.5% | -8.2% | -2.7% | – | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | -0.4% | 3.5% | 48.5% | 3.4% | |
| 81.0% | 41.8% | 62.7% | 15.8% | 70.5% | 118.6% | -26.0% | -85.0% | 4.0% | 3.3% | 48.6% | 81.9% | |
| 13.2% | 3.6% | -0.5% | -2.2% | -3.1% | 6.7% | -0.7% | -2.3% | -216.0% | -16.7% | 1.9% | 90.1% | |
| -88.5% | -73.7% | -96.9% | -41.4% | -99.6% | -146.5% | -15.6% | 19.6% | -126.9% | -97.5% | -61.5% | 8.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.